Kong Garheng

10% owner at Digital Transformation Opportunities Corp. · on record since Nov 9, 2023
Director at CEMPRA, INC. · on record since Mar 22, 2012
Director at ALIMERA SCIENCES INC · on record since Oct 4, 2012
10% owner at ALIMERA SCIENCES INC · on record since Oct 4, 2012
Director at LABORATORY CORP OF AMERICA HOLDINGS · on record since Dec 4, 2013
Director at Xeris Biopharma Holdings, Inc. · on record since Jun 5, 2026
Director at Ocugen, Inc. · on record since Dec 2, 2014
Director at Strongbridge Biopharma plc · on record since Jan 2, 2018
Director at AVEDRO INC · on record since Feb 19, 2019
10% owner at AVEDRO INC · on record since Feb 13, 2019
10% owner at CASTELLE \CA\ · on record since Jul 31, 2019
Director at Equinox International, Inc. · on record since Nov 7, 2019
10% owner at Equinox International, Inc. · on record since Nov 7, 2019
See Remarks at CASTELLE \CA\ · on record since May 19, 2020

Insider trading activity of Kong Garheng

Transactions on record: 137; since Mar 22, 2012

Open-market buys: 4; $5M

Open-market sells: 5; $9.4M

Companies traded: 9; last filing Jun 5, 2026

Figures computed from official regulatory filings — methodology.

Companies where Kong Garheng has traded

Xeris Biopharma Holdings, Inc.21 tx · $249.5K · Jun 5, 2026
LABORATORY CORP OF AMERICA HOLDINGS40 tx · Feb 13, 2026
Equinox International, Inc.15 tx · $10.7M · Mar 28, 2023
ALIMERA SCIENCES INC12 tx · Jan 6, 2023
Strongbridge Biopharma plc9 tx · $136.2K · Oct 6, 2021
CASTELLE \CA\15 tx · $11.5M · May 19, 2020
AVEDRO INC12 tx · $2M · Nov 26, 2019
Ocugen, Inc.4 tx · Jun 19, 2018
CEMPRA, INC.9 tx · $49.3K · Jun 14, 2018

Track record of Kong Garheng

Statistical track record

Free

Open-market buys: 7

Last buy: Nov 18, 2022

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of Kong Garheng

Co-insiders of Kong Garheng

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Xeris Biopharma Holdings, Inc.	Jun 5, 2026	Award	24,193	0.00 USD	$0	SEC
Xeris Biopharma Holdings, Inc.	Jun 5, 2026	AwardD	32,996	6.15 USD	$202.9K	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 13, 2026	ExerciseD	-897	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 13, 2026	Exercise	897	—	—	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 12, 2026	AwardD	773	0.00 USD	$0	SEC
Xeris Biopharma Holdings, Inc.	Jun 4, 2025	Award	50,000	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 13, 2025	AwardD	897	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 10, 2025	ExerciseD	-944	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 10, 2025	Exercise	944	—	—	SEC
Xeris Biopharma Holdings, Inc.	Jun 5, 2024	Award	50,000	0.00 USD	$0	SEC
Xeris Biopharma Holdings, Inc.	Apr 1, 2024	Other	6,474	—	—	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 8, 2024	Exercise	947	—	—	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 8, 2024	AwardD	944	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 8, 2024	ExerciseD	-947	0.00 USD	$0	SEC
Xeris Biopharma Holdings, Inc.	Jun 7, 2023	Award	42,500	0.00 USD	$0	SEC
Equinox International, Inc.	Mar 28, 2023	AwardD	75,000	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 14, 2023	ExerciseD	-742	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 14, 2023	Exercise	742	—	—	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 9, 2023	AwardD	849	0.00 USD	$0	SEC
ALIMERA SCIENCES INC	Jan 6, 2023	AwardD	6,000	0.00 USD	$0	SEC
Equinox International, Inc.	Nov 22, 2022	BuyD	335,000	2.00 USD	$670K	SEC
Xeris Biopharma Holdings, Inc.	Jun 9, 2022	AwardD	25,000	0.00 USD	$0	SEC
Xeris Biopharma Holdings, Inc.	Jun 9, 2022	Award	15,000	0.00 USD	$0	SEC
Equinox International, Inc.	Mar 28, 2022	AwardD	25,000	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 15, 2022	AwardD	742	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Xeris Biopharma Holdings, Inc.	Jun 5, 2026	Award	24,193	0.00 USD	$0	SEC
Xeris Biopharma Holdings, Inc.	Jun 5, 2026	AwardD	32,996	6.15 USD	$202.9K	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 13, 2026	ExerciseD	-897	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 13, 2026	Exercise	897	—	—	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 12, 2026	AwardD	773	0.00 USD	$0	SEC
Xeris Biopharma Holdings, Inc.	Jun 4, 2025	Award	50,000	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 13, 2025	AwardD	897	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 10, 2025	ExerciseD	-944	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 10, 2025	Exercise	944	—	—	SEC
Xeris Biopharma Holdings, Inc.	Jun 5, 2024	Award	50,000	0.00 USD	$0	SEC
Xeris Biopharma Holdings, Inc.	Apr 1, 2024	Other	6,474	—	—	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 8, 2024	Exercise	947	—	—	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 8, 2024	AwardD	944	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 8, 2024	ExerciseD	-947	0.00 USD	$0	SEC
Xeris Biopharma Holdings, Inc.	Jun 7, 2023	Award	42,500	0.00 USD	$0	SEC
Equinox International, Inc.	Mar 28, 2023	AwardD	75,000	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 14, 2023	ExerciseD	-742	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 14, 2023	Exercise	742	—	—	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 9, 2023	AwardD	849	0.00 USD	$0	SEC
ALIMERA SCIENCES INC	Jan 6, 2023	AwardD	6,000	0.00 USD	$0	SEC
Equinox International, Inc.	Nov 22, 2022	BuyD	335,000	2.00 USD	$670K	SEC
Xeris Biopharma Holdings, Inc.	Jun 9, 2022	AwardD	25,000	0.00 USD	$0	SEC
Xeris Biopharma Holdings, Inc.	Jun 9, 2022	Award	15,000	0.00 USD	$0	SEC
Equinox International, Inc.	Mar 28, 2022	AwardD	25,000	0.00 USD	$0	SEC
LABORATORY CORP OF AMERICA HOLDINGS	Feb 15, 2022	AwardD	742	0.00 USD	$0	SEC